I Volf
Overview
Explore the profile of I Volf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoetzenecker K, Assinger A, Lichtenauer M, Mildner M, Schweiger T, Starlinger P, et al.
Basic Res Cardiol
. 2012 Aug;
107(5):292.
PMID: 22899170
Although epicardial blood flow can be restored by an early intervention in most cases, a lack of adequate reperfusion at the microvascular level is often a limiting prognostic factor of...
2.
Assinger A, Laky M, Schabbauer G, Hirschl A, Buchberger E, Binder B, et al.
J Thromb Haemost
. 2011 Jan;
9(4):799-809.
PMID: 21251195
Background: Periodontitis represents a chronic infection of supportive dental tissues by distinct gram-negative bacteria. It is characterized by chronic and local inflammation as well as transient bacteremia with frequently occurring...
3.
Pollreisz A, Assinger A, Hacker S, Hoetzenecker K, Schmid W, Lang G, et al.
Br J Dermatol
. 2008 Jun;
159(3):578-84.
PMID: 18565176
Background: Intravenous immunoglobulins (IVIg) and cytomegalovirus immunoglobulins (CMVIg) are currently finding increased acceptance in clinical states of high immune activity and in transplant recipients. A rare side-effect of their application...
4.
Blaicher A, Landsteiner H, Zwerina J, Leitgeb U, Volf I, Hoerauf K
Anaesthesia
. 2004 Oct;
59(11):1100-3.
PMID: 15479319
The place of cyclo-oxygenase (COX)-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in the peri-operative period remains under discussion. Due to the absence of COX-2 in platelets, the risk of bleeding in...
5.
Ekmekcioglu C, Mehrabi M, Glogar H, Jucewicz M, Volf I, Spieckermann P
Int J Clin Lab Res
. 2001 Feb;
30(3):133-40.
PMID: 11196071
The present study was designed to investigate whether oxidized low-density lipoprotein is accumulated in the left and right ventricular walls of patients with coronary heart disease (n=10) compared with patients...
6.
Moeslinger T, Friedl R, Volf I, Brunner M, Koller E, Spieckermann P
Can J Physiol Pharmacol
. 2000 Dec;
78(11):861-6.
PMID: 11100933
Padma 28 is a mixture of herbs used in traditional Tibetan medicine with anti-inflammatory activities. We investigated the effects of Padma 28 on nitric oxide (NO) production by the inducible...
7.
Volf I, Roth A, Cooper J, Moeslinger T, Koller E
FEBS Lett
. 2000 Oct;
483(2-3):155-9.
PMID: 11042272
Experimental low density lipoprotein (LDL) oxidation is usually performed using trace copper, although the in vivo relevance of this method has been called into question. Such LDL augment adenosine 5'-diphosphate...
8.
Volf I, Bielek E, Moeslinger T, Koller F, Koller E
Arterioscler Thromb Vasc Biol
. 2000 Aug;
20(8):2011-8.
PMID: 10938025
Conflicting reports exist about the effects of mildly or extensively oxidized low density lipoproteins (LDLs) on the reactivity of human platelets. This platelet response is mainly caused by modification of...
9.
Moeslinger T, Friedl R, Volf I, Brunner M, Koller E, Spieckermann P
FEBS Lett
. 2000 Aug;
478(1-2):95-9.
PMID: 10922476
Increased plasma levels of human lipoprotein(a) (Lp(a)) are highly correlated with the development of atherosclerotic lesions. During our study, we investigated the effects of native and hypochlorite oxidized lipoprotein(a) (ox-Lp(a))...
10.
Volf I, Roth A, Moeslinger T, Cooper J, Schmid W, Zehetgruber M, et al.
Thromb Res
. 2000 Mar;
97(6):441-9.
PMID: 10704653
Oxidized low density lipoproteins are closely associated with atherosclerosis and also might be directly involved in thrombosis because they have been shown to mediate a stimulating effect on human platelets....